Pharma Value Will Surge On Number And Quality Of New Products – EvaluatePharma
This article was originally published in The Pink Sheet Daily
Executive Summary
EvaluatePharma’s 2013 industry portrait, released June 24 at the DIA annual meeting in Boston, predicts a rebound in pharma sales with near 4% growth out to 2018.